CA2250115A1 - Fast disintegrating oral dosage form - Google Patents

Fast disintegrating oral dosage form

Info

Publication number
CA2250115A1
CA2250115A1 CA002250115A CA2250115A CA2250115A1 CA 2250115 A1 CA2250115 A1 CA 2250115A1 CA 002250115 A CA002250115 A CA 002250115A CA 2250115 A CA2250115 A CA 2250115A CA 2250115 A1 CA2250115 A1 CA 2250115A1
Authority
CA
Canada
Prior art keywords
dosage form
oral dosage
fast disintegrating
disintegrating oral
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002250115A
Other languages
French (fr)
Other versions
CA2250115C (en
Inventor
Pierre Humbert-Droz
Matthias Seidel
Rosa Martani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Consumer Healthcare SARL
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1997/001696 external-priority patent/WO1997038679A2/en
Publication of CA2250115A1 publication Critical patent/CA2250115A1/en
Application granted granted Critical
Publication of CA2250115C publication Critical patent/CA2250115C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

The invention relates to a solid pharmaceutical dosage form for oral administration, which disintegrates very rapidly when taken into the mouth. Moreover, the invention relates to an advantageous, non-expensive process for the manufacture of said solid oral pharmaceutical dosage forms.
CA002250115A 1996-04-16 1997-04-04 Fast disintegrating oral dosage form Expired - Fee Related CA2250115C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810236 1996-04-16
EP96810236.8 1996-04-16
PCT/EP1997/001696 WO1997038679A2 (en) 1996-04-16 1997-04-04 Fast disintegrating oral dosage form

Publications (2)

Publication Number Publication Date
CA2250115A1 true CA2250115A1 (en) 1997-10-23
CA2250115C CA2250115C (en) 2006-10-03

Family

ID=37101805

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002250115A Expired - Fee Related CA2250115C (en) 1996-04-16 1997-04-04 Fast disintegrating oral dosage form

Country Status (1)

Country Link
CA (1) CA2250115C (en)

Also Published As

Publication number Publication date
CA2250115C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
WO1997038679A3 (en) Fast disintegrating oral dosage form
HK1019858A1 (en) Process for forming solid oral dosage forms of valsartan.
CA2427815A1 (en) Controlled release hydrocodone formulations
YU21999A (en) Pharmaceutical compositions and procedure for the production thereof
CA2257303A1 (en) Biconvex rapidly disintegrating dosage forms
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
CA2275392A1 (en) New aqueous medicament preparations for the production of propellent gas-free aerosols
CA2183746A1 (en) Oral Vehicle Compositions
SI0636364T1 (en) Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
WO2002094774A3 (en) Oxcarbazepine dosage forms
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
UA32543C2 (en) Aryl acetamides having analgetic action, a PROCESS for preparation thereof, pharmaceutical composition and a PROCESS for preparation thereof
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
CA2227272A1 (en) Use of lipids as aids in the production of solid drug forms by melt extrusion
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
SG162605A1 (en) Pharmaceutical compositions
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
HK1039273A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
AU2001247848A1 (en) Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
HUP9601321A3 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
HUP9602640A2 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
ZA968134B (en) The production of vitamin-containing solid formulations.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140404